Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 12 studies | 28% ± 15% | |
peripheral blood | 9 studies | 23% ± 7% | |
eye | 5 studies | 27% ± 6% | |
liver | 5 studies | 23% ± 8% | |
heart | 4 studies | 24% ± 2% | |
uterus | 4 studies | 28% ± 7% | |
adipose | 4 studies | 18% ± 3% | |
placenta | 3 studies | 24% ± 6% | |
bone marrow | 3 studies | 23% ± 8% | |
breast | 3 studies | 21% ± 3% | |
intestine | 3 studies | 19% ± 3% | |
kidney | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 11316.37 | 653 / 653 | 100% | 172.75 | 604 / 605 |
lung | 100% | 10217.81 | 578 / 578 | 100% | 192.61 | 1151 / 1155 |
breast | 100% | 8806.73 | 459 / 459 | 99% | 242.79 | 1112 / 1118 |
esophagus | 100% | 5681.29 | 1444 / 1445 | 99% | 152.24 | 182 / 183 |
bladder | 100% | 6070.33 | 21 / 21 | 99% | 151.08 | 499 / 504 |
stomach | 100% | 6324.90 | 359 / 359 | 99% | 114.91 | 283 / 286 |
intestine | 100% | 5073.07 | 965 / 966 | 99% | 111.01 | 521 / 527 |
uterus | 100% | 6053.31 | 170 / 170 | 98% | 220.30 | 452 / 459 |
ovary | 100% | 14856.58 | 180 / 180 | 98% | 138.93 | 420 / 430 |
prostate | 100% | 8231.09 | 245 / 245 | 98% | 106.86 | 490 / 502 |
kidney | 100% | 6550.65 | 89 / 89 | 97% | 146.77 | 877 / 901 |
liver | 100% | 9381.57 | 226 / 226 | 97% | 96.04 | 393 / 406 |
skin | 100% | 9224.31 | 1809 / 1809 | 90% | 73.00 | 425 / 472 |
pancreas | 92% | 4183.11 | 303 / 328 | 95% | 146.17 | 169 / 178 |
adrenal gland | 100% | 7397.84 | 258 / 258 | 43% | 28.17 | 100 / 230 |
adipose | 100% | 9331.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8201.62 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 7979.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 167.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 241.90 | 1 / 1 |
heart | 99% | 6442.92 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 8617.51 | 902 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 119.18 | 27 / 29 |
muscle | 90% | 3537.88 | 725 / 803 | 0% | 0 | 0 / 0 |
brain | 18% | 353.28 | 475 / 2642 | 16% | 8.67 | 115 / 705 |
eye | 0% | 0 | 0 / 0 | 34% | 14.96 | 27 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_0060054 | Biological process | positive regulation of epithelial cell proliferation involved in wound healing |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_0060055 | Biological process | angiogenesis involved in wound healing |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0060046 | Biological process | regulation of acrosome reaction |
GO_0007155 | Biological process | cell adhesion |
GO_0061755 | Biological process | positive regulation of circulating fibrinogen levels |
GO_0002526 | Biological process | acute inflammatory response |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0006012 | Biological process | galactose metabolic process |
GO_0045136 | Biological process | development of secondary sexual characteristics |
GO_1905517 | Biological process | macrophage migration |
GO_0005989 | Biological process | lactose biosynthetic process |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006629 | Biological process | lipid metabolic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0002064 | Biological process | epithelial cell development |
GO_0007341 | Biological process | penetration of zona pellucida |
GO_0031526 | Cellular component | brush border membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0000138 | Cellular component | Golgi trans cisterna |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030175 | Cellular component | filopodium |
GO_0000139 | Cellular component | Golgi membrane |
GO_0030057 | Cellular component | desmosome |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0003831 | Molecular function | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity |
GO_0003945 | Molecular function | N-acetyllactosamine synthase activity |
GO_0035250 | Molecular function | UDP-galactosyltransferase activity |
GO_0008378 | Molecular function | galactosyltransferase activity |
GO_0004461 | Molecular function | lactose synthase activity |
GO_0030145 | Molecular function | manganese ion binding |
GO_0008092 | Molecular function | cytoskeletal protein binding |
Gene name | B4GALT1 |
Protein name | Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] Beta-1,4-galactosyltransferase 1 B4GALT1 protein (Beta-1,4-galactosyltransferase 1) Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-) |
Synonyms | GGTB2 |
Description | FUNCTION: [Beta-1,4-galactosyltransferase 1]: The Golgi complex form catalyzes the production of lactose in the lactating mammary gland and could also be responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. .; FUNCTION: [Processed beta-1,4-galactosyltransferase 1]: The cell surface form functions as a recognition molecule during a variety of cell to cell and cell to matrix interactions, as those occurring during development and egg fertilization, by binding to specific oligosaccharide ligands on opposing cells or in the extracellular matrix. . FUNCTION: Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. . |
Accessions | ENST00000535206.5 Q86XA6 P15291 ENST00000379731.5 [P15291-1] W6MEN3 W6MEN4 |